Valuation — not yet established
No valuation for Patara Pharma (PA101 global rights) is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Patara Pharma (PA101 global rights)
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2018 | Buyout/LBO† | — | ▮ | ▮ |
How Patara Pharma (PA101 global rights)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Patara Pharma (PA101 global rights), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- When did Patara Pharma (PA101 global rights) last raise?
- Patara Pharma (PA101 global rights) last raised in Sep 2018 (Buyout/LBO†).